- Home
- Publications
- Publication Search
- Publication Details
Title
Idiopathic pulmonary fibrosis: Current and future treatment
Authors
Keywords
-
Journal
Clinical Respiratory Journal
Volume 16, Issue 2, Pages 84-96
Publisher
Wiley
Online
2022-01-10
DOI
10.1111/crj.13466
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histologic factors associated with nintedanib efficacy in patients with idiopathic pulmonary fibrosis
- (2021) Masahiro Nemoto et al. PLoS One
- Exposure-Efficacy Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung Disease
- (2021) Ulrike Schmid et al. RESPIRATORY MEDICINE
- Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
- (2021) Miriana d’Alessandro et al. Cancers
- Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
- (2021) Yvette N. Lamb DRUGS
- Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production
- (2021) Fatmah Al‐Habeeb et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Trajectory modeling of endothelial-to-mesenchymal transition reveals galectin-3 as a mediator in pulmonary fibrosis
- (2021) Wangyue Jia et al. Cell Death & Disease
- Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
- (2021) Eleanor Valenzi et al. Frontiers in Immunology
- The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF)
- (2021) Feng Xu et al. EBioMedicine
- Molecular Signatures of Idiopathic Pulmonary Fibrosis
- (2021) Iain R Konigsberg et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment
- (2021) Moez Ghumman et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Epidemiology and Clinico-radiological features of Interstitial Lung Diseases
- (2020) Saira Jafri et al. Pakistan Journal of Medical Sciences
- Meaningful survival benefit for single lung transplantation in IPF patients over 65 years of age
- (2020) Peter Riddell et al. EUROPEAN RESPIRATORY JOURNAL
- Pamrevlumab for the treatment of idiopathic pulmonary fibrosis
- (2020) Giacomo Sgalla et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Single versus bilateral lung transplantation in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
- (2020) Diandian Li et al. PLoS One
- Transplantation pulmonaire pour fibrose idiopathique
- (2020) Jérôme Le Pavec et al. PRESSE MEDICALE
- Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary care
- (2020) David Thickett et al. BMJ Open
- Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
- (2020) Taylor S. Adams et al. Science Advances
- The Idiopathic Pulmonary Fibrosis Cell Atlas
- (2020) Nir Neumark et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Systematic Review and Meta-analysis of Pirfenidone, Nintedanib, and Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
- (2020) Enrica Di Martino et al. ANNALS OF PHARMACOTHERAPY
- Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy
- (2020) Yuzo Suzuki et al. RESPIROLOGY
- Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
- (2020) Paolo Cameli et al. Frontiers in Molecular Biosciences
- Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
- (2020) Vincent Picozzi et al. ESMO Open
- Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis
- (2020) Lisa Lancaster et al. Contemporary Clinical Trials
- Safety and efficacy of pirfenidone and nintedanib in patients with Idiopathic Pulmonary Fibrosis and carrying a telomere related gene mutation
- (2020) Aurélien Justet et al. EUROPEAN RESPIRATORY JOURNAL
- Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis
- (2020) Nikhil Hirani et al. EUROPEAN RESPIRATORY JOURNAL
- An updated patent review of autotaxin inhibitors (2017–present)
- (2020) Zehui Tan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Lung transplantation for idiopathic pulmonary fibrosis
- (2019) Peter M George et al. Lancet Respiratory Medicine
- Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation
- (2019) Tobias Veit et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis
- (2019) Amit Taneja et al. CLINICAL PHARMACOKINETICS
- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
- (2019) Ganesh Raghu et al. Lancet Respiratory Medicine
- Human pentraxin 2 protein treatment for IPF
- (2019) Argyris Tzouvelekis et al. Lancet Respiratory Medicine
- Management of Idiopathic Pulmonary Fibrosis
- (2019) Roy Pleasants et al. ANNALS OF PHARMACOTHERAPY
- Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)
- (2019) Shigeki Saito et al. Journal of Thoracic Disease
- Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Luca Richeldi et al. Lancet Respiratory Medicine
- Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis
- (2019) Hasancan Bilgili et al. Journal of Clinical Medicine
- Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
- (2019) Bridget F. Collins et al. European Respiratory Review
- The therapy of idiopathic pulmonary fibrosis: what is next?
- (2019) Vivien Somogyi et al. European Respiratory Review
- Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
- (2019) Elisabetta Balestro et al. Medicina-Lithuania
- Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
- (2019) J. H. Fisher et al. BMC Pulmonary Medicine
- First‐in‐human high‐cumulative‐dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline
- (2019) Alexander Averyanov et al. Stem Cells Translational Medicine
- Targeting exosome‐associated human antigen R attenuates fibrosis and inflammation in diabetic heart
- (2019) Prem Kumar Govindappa et al. FASEB JOURNAL
- Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease
- (2019) Wim A. Wuyts et al. RESPIRATION
- Breathe, breathe in the air: the anti-CCN2 antibody pamrevlumab (FG-3019) completes a successful phase II clinical trial for idiopathic pulmonary fibrosis
- (2019) Andrew Leask Journal of Cell Communication and Signaling
- Single versus Double Lung Transplantation in Pulmonary Fibrosis: Impact of Age and Pulmonary Hypertension
- (2018) Mauricio A. Villavicencio et al. ANNALS OF THORACIC SURGERY
- Treatment of Interstitial Lung Disease associated cough: CHEST guideline and expert panel report
- (2018) Surinder S. Birring et al. CHEST
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biomarkers in idiopathic pulmonary fibrosis
- (2018) F. Drakopanagiotakis et al. MATRIX BIOLOGY
- Patients’ experiences of coping with Idiopathic Pulmonary Fibrosis and their recommendations for its clinical management
- (2018) Sameera Senanayake et al. PLoS One
- Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey
- (2018) Gregory P. Cosgrove et al. BMC Pulmonary Medicine
- Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
- (2018) David A Lynch et al. Lancet Respiratory Medicine
- Lung transplantation in idiopathic pulmonary fibrosis
- (2018) Anupam Kumar et al. Expert Review of Respiratory Medicine
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Fifth Adult Lung and Heart–Lung Transplant Report—2018; Focus Theme: Multiorgan Transplantation
- (2018) Daniel C. Chambers et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
- (2018) Chad A. Newton et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary fibrosis: Genetic analysis of telomere-related genes, telomere length measurement-or both?
- (2018) Caroline Kannengiesser et al. RESPIROLOGY
- Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study
- (2018) Sebastiaan Tuyls et al. TRANSPLANT INTERNATIONAL
- Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre
- (2018) E. Bargagli et al. Pulmonology
- Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading—A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation
- (2017) Gregory I. Snell et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis
- (2017) Nicolas Desroy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Idiopathic pulmonary fibrosis
- (2017) Luca Richeldi et al. LANCET
- Clubbing in patients with fibrotic interstitial lung diseases
- (2017) M.J.G. van Manen et al. RESPIRATORY MEDICINE
- Etiology and treatment of cough in idiopathic pulmonary fibrosis
- (2017) Christine L. Vigeland et al. RESPIRATORY MEDICINE
- The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
- (2017) Fernando J Martinez et al. Lancet Respiratory Medicine
- Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways
- (2017) Xian-Long Zhou et al. Scientific Reports
- Update on Pulmonary Fibrosis: Not All Fibrosis Is Created Equally
- (2016) Maxwell L. Smith ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
- (2016) Bram Rochwerg et al. BMC Medicine
- Shall we call them “telomere-mediated”? Renaming the idiopathic after the cause is found
- (2016) Samantha J. Merck et al. EUROPEAN RESPIRATORY JOURNAL
- Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
- (2016) Bernt van den Blink et al. EUROPEAN RESPIRATORY JOURNAL
- The Intersection of GERD, Aspiration, and Lung Transplantation
- (2016) Marco G. Patti et al. Journal of Laparoendoscopic & Advanced Surgical Techniques
- Auscultation of Velcro Crackles is Associated With Usual Interstitial Pneumonia
- (2016) Jacobo Sellarés et al. MEDICINE
- Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis
- (2016) Diptiman Chanda et al. Scientific Reports
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
- (2015) Paul W. Noble et al. EUROPEAN RESPIRATORY JOURNAL
- Thalidomide prevents cigarette smoke extract-induced lung damage in mice
- (2015) Chiharu Tabata et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Clinical outcomes of lung transplant recipients with telomerase mutations
- (2015) Sofya Tokman et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
- (2015) David Weill et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis
- (2015) Nevins W Todd et al. Expert Review of Respiratory Medicine
- Diabetes Is a Major Risk Factor for Mortality After Lung Transplantation
- (2014) K. L. Hackman et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Lung transplantation in telomerase mutation carriers with pulmonary fibrosis
- (2014) L. L. Silhan et al. EUROPEAN RESPIRATORY JOURNAL
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Adult Lung and Heart–Lung Transplant Report—2014; Focus Theme: Retransplantation
- (2014) Roger D. Yusen et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Distinct Fcγ Receptors Mediate the Effect of Serum Amyloid P on Neutrophil Adhesion and Fibrocyte Differentiation
- (2014) Nehemiah Cox et al. JOURNAL OF IMMUNOLOGY
- Serum amyloid P: a systemic regulator of the innate immune response
- (2014) Nehemiah Cox et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistent Lung Inflammation and Fibrosis in Serum Amyloid P Component (Apcs-/-) Knockout Mice
- (2014) Darrell Pilling et al. PLoS One
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
- (2014) Ganesh Raghu et al. Lancet Respiratory Medicine
- Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis. Potential for Clinical Testing
- (2013) Rebecca L. Toonkel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Autotaxin Emerges as a Therapeutic Target for Idiopathic Pulmonary Fibrosis
- (2013) Andrew M. Tager AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis
- (2013) Maureen R. Horton et al. ANNALS OF INTERNAL MEDICINE
- A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
- (2013) Brett Ley et al. ANNALS OF INTERNAL MEDICINE
- Quantitative Computed Tomography Imaging of Interstitial Lung Diseases
- (2013) Brian J. Bartholmai et al. JOURNAL OF THORACIC IMAGING
- Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
- (2013) M.R. Dillingh et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2012) Nikos Oikonomou et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Human antigen R contributes to hepatic stellate cell activation and liver fibrosis
- (2012) Ashwin Woodhoo et al. HEPATOLOGY
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Interobserver Variability in the CT Assessment of Honeycombing in the Lungs
- (2012) Takeyuki Watadani et al. RADIOLOGY
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
- (2011) D. B. Sprunger et al. EUROPEAN RESPIRATORY JOURNAL
- Integrating mechanisms of pulmonary fibrosis
- (2011) Thomas A. Wynn JOURNAL OF EXPERIMENTAL MEDICINE
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Bilateral Lung Transplantation Offers Better Long-Term Survival, Compared With Single-Lung Transplantation, for Younger Patients With Idiopathic Pulmonary Fibrosis
- (2010) Seth D. Force et al. ANNALS OF THORACIC SURGERY
- PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis
- (2010) J.S. Duffield et al. DRUG NEWS & PERSPECTIVES
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
- (2010) Lynne A. Murray et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
- (2009) Antje Moeller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pentraxins: Multifunctional proteins at the interface of innate immunity and inflammation
- (2009) Livija Deban et al. BIOFACTORS
- Serum amyloid P inhibits dermal wound healing
- (2008) Bindi Naik-Mathuria et al. WOUND REPAIR AND REGENERATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started